HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Wednesday, 4 February 2015
ScHARR-TAG have been allocated the following topic by NIHR/NICE:
Certolizumab pegol for treating rheumatoid arthritis following inadequate response to a TNF inhibitor [ID824]